NEW YORK (GenomeWeb News) –Synthetic Genomics has struck a biofuel research and development agreement with ExxonMobil Research and Engineering Company that could bring in up to $300 million for the genomics firm, the companies said today.

The agreement to develop biofuel from photosynthetic algae that would be compatible with gasoline and diesel fuels could bring in $300 million to SGI if certain milestones are met. Exxon plans to spend up to another $300 million internally to support the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.